Detalhe da pesquisa
1.
PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection.
PLoS Pathog
; 17(5): e1009594, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34048504
2.
Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open-Label Phase 1 Multiple Ascending Dose and Food Effect Study.
Antimicrob Agents Chemother
; 64(11)2020 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32816721
3.
Dose-Dependent Infectivity of Aseptic, Purified, Cryopreserved Plasmodium falciparum 7G8 Sporozoites in Malaria-Naive Adults.
J Infect Dis
; 220(12): 1962-1966, 2019 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31419294
4.
A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area.
PLoS Negl Trop Dis
; 17(3): e0011236, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36996185
5.
EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Brazil.
Trials
; 23(1): 185, 2022 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35236394
6.
PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial.
EClinicalMedicine
; 52: 101579, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35928033